Savara Inc.

SVRA
$5.08 (+ $0.36 + 7.63%)
Last updated: 2026-05-21 02:00 UTC
SVRA Metrics
Exchange
🇺🇸 NASDAQ XNGS
Nasdaq/NGS (Global Select Market)United StatesAmerica/New_York
SectorHealthcare
IndustryBiotechnology
ISINUS8051111016
CUSIP805111101
Market Price5.08
Dividend Yield N/A
Dividend Growth
1YN/A
3YN/A
5YN/A
10YN/A
Annual Dividend N/A
Latest Payout ($)N/A
Latest Payout DateN/A
Dividend FrequencyNone
P/E RatioN/A
EPS-0.53
Market Cap$1.3B
Book Value0.45
Price to Book14.286
Beta0.22
52w High7.0
52w Low1.89
Next Earnings DateN/A

Savara Inc. trades under ticker SVRA on NASDAQ as a stock. Use this page to review stock price, share price, dividends, and price history. The page also shows Healthcare exposure. Identifiers: ISIN US8051111016, CUSIP 805111101. Also searched as Savara.

Related researchSVRA stock priceSVRA share price805111101Savara stockSavara share price
About the Company
Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. The company's lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase 3 development stage for the treatment of autoimmune pulmonary alveolar proteinosis. The company was founded in 2007 and is headquartered in Langhorne, Pennsylvania.
Price History